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Abstract 
Dedicator of cytokinesis 8 (DOCK8) deficiency is an innate error of adaptive immunity 
characterized by recurrent infections with viruses, bacteria and fungi, very high serum IgE 
concentrations and a progressive deterioration of T- and B cell-mediated immunity. We 
studied the genetic and immunological features of two sisters (aged 11 and 6 years). 
Mutational analysis of genomic DNA and cDNA from the patients and their parents, by a 
combination of PCR and bidirectional targeted sequencing, failed to localize the mutation site. 
However, a multiplex ligation-dependent probe amplification (MLPA) assay revealed two 
novel large deletions, del1-14 exons and del8-18 exons, of DOCK8 in both patients. 
Immunoblot analysis demonstrated that DOCK8 protein was absent from the peripheral blood 
lymphocytes of both patients. These data suggest that compound heterozygous del1-14 exons 
and del8-18 exons mutations result in a loss of function of DOCK8 protein and a typical 
DOCK8 deficiency phenotype.  
 
Introduction 
Dedicator of cytokinesis 8 (DOCK8) deficiency (OMIM #611432), caused by a biallelic loss-
of-function mutation of DOCK8, is characterized by food allergy, asthma, atopic dermatitis, 
eosinophilia and high serum IgE levels. Affected individuals typically suffer from recurrent 
respiratory tract infections and are highly susceptible to cutaneous viral infections caused by 
herpesviruses, Molluscum contagiosum virus, and Human papilloma virus, and fungal 
diseases, such as chronic mucocutaneous candidiasis (CMC) (1-5). The less frequent and 
more unusual clinical signs observed in patients with DOCK8 deficiency include 
gastrointestinal infections, granulomatous soft tissue lesions in the central nervous system, 
leiomyosarcoma, lymphoma, squamous cell carcinoma and autoimmunity (3, 4, 6, 7). DOCK8 
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deficiency was initially thought to be the autosomal recessive form of hyper IgE syndrome 
(HIES) (2, 8, 9, 10), but it actually fulfills the criteria of severe combined immunodeficiency 
in most affected patients and only rarely presents with a mild phenotype, such as isolated 
atopic dermatitis (7). DOCK8 mutations may be homozygous or compound heterozygous and 
typically result in a  loss of function of DOCK8. The human DOCK8 gene consists of 48 
exons and is spread over 250 kb on chromosome 9p24.3 (1).   DOCK8 is one of the 11 
members of DOCK180 family of atypical guanine nucleotide-exchange factors, which 
function as activators of small G proteins and are involved in regulating the actin cytoskeleton 
(11-13). 
 
Immunological studies in patients with DOCK8 deficiency have revealed T-cell 
depletion, impaired T-cell expansion in vitro, and secondary antibody responses to specific 
antigens (4, 14-16). Levels of B-cell proliferation and immunoglobulin production upon 
stimulation with Toll-like receptor (TLR)) 9 were considerably lower in DOCK8-deficient 
patients than in controls (16). DOCK8 may function as an adaptor linking TLR-MyD88 
signaling pathways essential for TLR-9-driven B-cell activation and DOCK8-deficient patient 
have fewer CD27-positive memory B cells, potentially accounting for their low IgM level 
(17). DOCK8 plays a key role in CD8 T-cell survival and function in both humans and mice 
(14, 15). Impaired CD4+IL-17+ T cell-mediated immunity has also been reported, potentially 
accounting for the high level of susceptibility of affected patients to chronic mucocutaneous 
candidiasis (18). The identification of DOCK8 mutations is challenging, because large 
deletions may overlap and the data obtained with Sanger sequencing technology may be 
misleading. We report here two patients who presented with a DOCK8 deficiency phenotype 
caused by previously unknown large deletions of DOCK8.  
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Materials and Methods 
Patients 
All the studies reported here were approved by the Regional Ethics Committee of the 
University of Debrecen Medical and Health Science Center. Informed consent was obtained 
from the parents. We analyzed two non consanguineous Hungarian girls, patient P1, who was 
11 years old, and her sister, patient P2, who was six years old, both with recurrent viral and 
bacterial infections and CMC. The patients’ mother is healthy; their father has had recurrent 
herpesvirus disease and allergic rhinitis. Patient P1 was referred to our department at the age 
of nine years, with HIES diagnosed on the basis of high serum IgE concentration, eosinophilia 
and atopic dermatitis, which had begun at the age of two and a half years (Table 1). She 
received routine immunization with no complications. On admission, she had oral and nail 
candidiasis, gingivitis and bronchiectasis. She had had recurrent Herpes simplex virus skin 
infection since the age of two years, which had spread to both eyelids and caused keratitis, 
which was effectively treated with acyclovir. She was repeatedly treated for upper and lower 
respiratory tract infections and bacterial skin infections. She had marked T-cell lymphopenia 
and a moderately low number of natural killer cells, low serum IgM and high IgA 
concentrations and low levels of anti-pneumococcal antibodies (Table 1). She had suffered 
from severe allergy to various food allergens. At the age of 10 years, she was treated at 
another hospital for an intracerebral abscess of undefined origin, which resulted in a severe 
deterioration of her physical, mental and psychological condition. She is now receiving 
rehabilitation support. Cytogenetic studies her to have a normal karyotype. Here National 
Institutes of Health (NIH) score was only 35, suggesting that autosomal dominant (AD)-HIES 
was not likely, but the full-length STAT3 (signal transducer and activator of transcription 3) 
gene was analyzed and found to have a wild-type sequence. Based on the patient’s history, 
clinical signs and immunological findings, DOCK8 deficiency was suspected and the DOCK8 
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gene was analyzed. Patient P2, the sister of P1, was referred to us at the age of four years, 
with suspected HIES. She underwent routine vaccination with no complications. She had had 
atopic dermatitis since the age of 2.5 years, and had a high serum IgE level, and moderately 
high blood eosinophil counts. Recurrent respiratory tract infections, including pneumonia, 
began at the age of 10 months. Serum IgM level was low, IgA level was high and P2 had T-
cell lymphopenia (Table 1). Her NIH score was 15, arguing against AD-HIES, and an analysis 
of the STAT3 gene revealed a wild-type sequence with no mutations. At the age of five years, 
P2 underwent successful hematopoietic stem cell transplantation, with matched unrelated 
donor cells, at another hospital.  
 
Immunological assays 
Serum immunoglobulin isotypes M, G, A, and E were determined in routine 
laboratory assays. Lymphocyte subsets were analyzed with a Coulter 500 flow 
cytometer. Enzyme-linked immunosorbent assays were used to quantify anti-
capsular IgG antibodies against pneumococcal polysaccharides. 
 
DNA sequencing  
Genomic DNA (gDNA) was isolated from peripheral blood mononuclear cells 
(PBMCs). Exons 1 to 48 of DOCK8 and the flanking intronic regions were 
amplified by polymerase chain reaction (PCR). The primer sequences are available 
on request. Total RNA was isolated from PBMCs and RNA was reverse-transcribed 
with the Superscript III first-strand synthesis supermix (Invitrogen). Complementary 
DNA (cDNA) sequencing of DOCK8 and glyceraldehyde 3-phosphate 
dehydrogenase cDNAs was performed after PCR amplification across all exons. The 
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primer sequences are available on request. Mutational analysis was performed with 
the BigDye Terminator Cycle sequencing kit, and an ABI 3130 analyzer 
(AppliedBiosystems, Foster City, CA). The numbering of DNA and RNA mutations 
was based on the cDNA sequence (Ensemble: ENST00000453981), with the A of 
the translation initiation codon counted as the first nucleotide (19). 
 
MLPA 
MLPA (multiplex ligation-dependent probe amplification) analysis was carried out according 
to the kit manufacturer's instructions (MRC-Holland, Amsterdam, The Netherlands). Briefly, 
300 ng DNA was denatured and hybridized overnight at 60°C with the SALSA probe mix 
P385-A1 DOCK8 and P386-A1DOCK8-STAT3. Samples were then treated with DNA ligase 
for 15 min at 54°C. The reaction was stopped by incubation at 98°C for 5 min. PCR 
amplification was carried out with specific fluorescent labeled PCR primers.  
Amplification products were subjected to electrophoresis on an ABI PRISM 3100 Genetic 
Analyzer. Fluorescence intensity was measured after inter-sample and intra-sample 
normalization. 
 
Western blotting  
Protein extracts of PBMCs were subjected to denaturing polyacrylamide gel electrophoresis 
and the bands obtained were transferred to PVDF membranes (Millipore Corp, Billericay, 
MA). For detection, the blot was incubated with polyclonal rabbit anti-DOCK8 or anti-actin 
antibodies (Sigma-Aldrich),  and then with horse-radish peroxidase-conjugated anti-rabbit 
IgG (GE Healthcare, Buckinghamshire, UK). DOCK8 and actin were visualized by 
chemiluminescence (Termo Scientific, Rockford, IL). 
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Results  
Analysis of the DOCK8 gDNA with PCR amplicons  
PCR amplification of exons and flanking intronic fragments of the DOCK8 gDNA gave 
normal bands for exons 1-8 and 14-48 (Fig. 1a). We sequenced the exon 8 and exon 14 
fragments from P1 and found that we had actually amplified fragments from tubulin-tyrosine 
ligase-like protein 7 (TTLL7) rather than the DOCK8-specific exon 8 sequences observed in 
controls (Supplementary Fig. 1). Amplification of exon 14 fragments from the patients’ DNA 
actually led to amplification of part of the PR domain-containing protein 11 (PRDM11) gene, 
rather than the DOCK8-specific exon 14 sequences obtained with the controls (Supplementary 
Fig. 1). Furthermore, we obtained single bands on the amplification of exon 12 from both 
patients. The sequencing of these bands showed them to be p21 protein (CDC42/Rac)-
activated kinase 6 (PAK6)-specific sequences in the patients and DOCK8-specific sequences 
in the controls (Supplementary Fig. 1). These experiments suggested that the primers used to 
amplify exons 8, 12, and 14 were able to bind to the sequences of genes other than DOCK8. 
Amplification of gDNA from the mother gave normal bands for exons 8 to 14 (Fig. 1b) and 
for all the other exons (1-7 and 15-48) (not shown). Similar findings were obtained with the 
father: all of the exons from 1 to 48 could be amplified (Fig. 1c). These data suggest that both 
parents have biallelic or monoallelic wild-type DOCK8 sequences.  
 
Analysis of DOCK8 cDNA with PCR amplicons  
We then designed primers for the amplification of cDNA from the patients and the mother 
(the father was not available for cDNA isolation). We checked the quality of cDNA samples, 
by first amplifying the GAPDH cDNA as a control (Fig. 1b and 1c). Equivalent amplicons 
were obtained with samples from patients or controls. However, by contrast, no band was 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
obtained by amplification of the whole cDNA isolated from the patients (Fig.1c). We 
performed PCR amplifications on samples from the patients and the mother, with primers 
amplifying the cDNA sequences of exons 1-15 and 3-26. We detected a deletion of exons 1 
and15 in the patients, but not in the mother (Fig. 1c). Further experiments with primers 
designed to amplify exons 3 and 26 clearly indicated the presence of the deletion in both 
patients, but not in the mother (Fig. 1c). Sequencing of the amplified exons 3-26 indicated 
that both patients carried homozygous deletions of exons 8-18 (Fig. 2). However, the 
sequencing of the sample from the mother presented us with a further challenge, because the 
electropherograms showed the sequence present to be wild-type (Fig. 2).  
 
Identification of DOCK8 mutation sites by MLPA 
MLPA was performed for both patients and clearly showed that patient P1 had a compound 
heterozygous deletion mutation affecting exons 1-14 and exons 8-18 (Fig. 3a). The mother 
proved to be heterozygous for the deletion of exons 1-14, whereas the father was 
heterozygous for the deletion of exons 8-18 (Fig. 3b-d). These data suggest that the MLPA 
probe set used here is potentially valuable for the identification of large deletions of DOCK8 
and should used as a complement to Sanger sequencing analysis.   
 
Immunoblotting 
Figure 4 shows immunoblots for DOCK8 protein in the blood cells of the two patients and a 
healthy control. Lysates were obtained from freshly isolated PBMCs. Consistent with the 
clinical, immunological and genetic data, we were unable to detect DOCK8 protein on 
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western blots of the patients’ PBMC extracts, whereas this protein was clearly detected on 
control blots (Fig. 4).  
 
Discussion 
The diagnosis of DOCK8 deficiency is challenging in clinical, immunological and genetic 
terms. In particular, the differential diagnosis of DOCK8 deficiency and AD-HIES caused by 
STAT3 mutation on the basis of clinical signs is difficult because the signs of these two 
diseases overlap (Table 2). Most of the typical clinical findings of AD-HIES are due to 
connective tissue involvement occurring in children of school age (Table 2). Thus, these signs 
and other overlapping signs are not useful for clinical diagnosis. The suspicion of DOCK8 
deficiency is increased by the presence of allergy, including life-threatening food allergy in 
some cases, recurrent viral infections, T-cell lymphopenia and dysgammaglobulinemia (Table 
2). The higher rates of malignancy and mortality in patients with DOCK8 deficiency than in 
patients with AD-HIES requires close attention and the careful follow-up of patients from 
early childhood.   
 
 The identification of deletions in large genes, such as DOCK8, is important for the 
definitive diagnosis of the disease. The precise diagnosis of DOCK8 deficiency caused by 
point mutations or small deletions can be made by Sanger sequencing. MLPA has been 
introduced into DNA diagnostics for the detection of copy number variations due to deletions 
and duplications in several diseases (20-22). One of the objectives of this study was to 
confirm the clinical and immunological diagnosis of DOCK8 deficiency, by PCR 
amplification and Sanger sequencing. However, these traditional techniques failed to detect 
the DOCK8 deletion, probably due to the overlap between the deletions identified in the two 
heterozygous parents. We therefore decided to use MLPA, a rapid and reliable assay for 
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detecting the large deletions commonly occurring in patients with DOCK8 mutations. MLPA 
probes covering all 48 exons of DOCK8 were available, making it possible to refine the 
definition of the breakpoints of exon deletions not clearly defined by PCR and targeted 
sequencing.  
 Deletions account for a large proportion of the mutations affecting the DOCK8 gene. 
Previous studies have suggested that, of the 30 different genomic mutations identified in 32 
DOCK8-deficient patients from 23 families, 63% were large deletions, 17% were point 
mutations that altered splicing, 10% were nonsense point mutations, and 10% were small 
indels (1, 2, 23, 24). An updated review of the current literature showed that 15 (40.5%) of the 
37 DOCK8 mutations reported up to datewere large deletions (1, 2, 5, 7, 23-30). 
In summary, we diagnosed DOCK8 deficiency clinically and immunologically in two sisters 
and used MLPA analysis to detect deletions of the DOCK8 gene in the patients and their 
heterozygous parents. The deletions in the patients resulted in a DOCK8 frameshift at amino-
acid position 276 and a stop codon leading to the termination of protein synthesis at amino-
acid position 326. MLPA proved to be a powerful tool in our hands, making it possible us to 
confirm the clinical diagnosis of the disease. We suggest that MLPA could be used to screen 
for large deletions of DOCK8 in routine genetic diagnosis and for the prenatal genetic 
screening of DOCK8 deficiency. This technique was informative, identifying two new 
deletions of DOCK8, the exons 1-14 and exons 8-18 deletions present in the compound 
heterozygous patients and individually in the heterozygous state in the parents (exons 1-14 
deletion in the mother and exons 8-18 deletion in the father). This is the first report 
demonstrating confirmation of the clinical diagnosis of DOCK8 deficiency by MLPA.      
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Table 1 Clinical and laboratory features of the patients with DOCK8 deficiency 
Patient    Patient P1    Patient P2   
Age (yr)    11    6 
Sex     female    female  
Pneumonia    3 yr (3-4 per yr)#  10 mo (1-2 per yr) 
Bronchitis    2 yr (1-2 per year)  2 yr (1-2 per year) 
Sinusitis    2 yr (1-2 per year)  2 yr (1-2 per year) 
Otitis media     2,5 yr (1-2 per year)  1.5 yr (1-2 per year) 
Bacterial skin infection  2.5 yr    no 
Mucocutaneous candidiasis  2.5 yr    no 
Genital candidiasis   3.0 yr (recurrent)  2.5 yr (recurrent) 
Herpes simplex virus infection 2 yr    no 
Atopic dermatitis   2.5 yr    2.5 yr 
Food allergy    2.5 yr*    2.5 yr (egg) 
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Asthma    3.0 yr    no 
            
Normal 
Eosinophils (G/l)   7.40    0.68  0.01-0.60 
Lymphocytes (G/l)   1.83    2.12   0.9-4.44 
 CD3+ (%)   30.2    34.1  55-78 
 CD4+ (%)    13.2    16.4  27-53  
CD8+ (%)   17.4    10.5  19-34 
CD19+ (%)   64.3    48.4  10-31 
CD3-CD56+ (%)  2.30    13.5  4-26 
Serum immunoglobulins 
 IgM (g/l)   0.46    0.14  0.52-3.25 
IgG (g/l)   12.9    10.1  5.4-15.1 
IgA (g/l)   2.60    2.63  0.52-1.50 
IgE (kU/l)   7071    604  <120 
Specific antibodies 
Str. pneumoniae (μg/ml)¶ 0,38    1.03  > 9.2 
#Age at first episode (recurrence rate); *Patient P1 is allergic to soy bean, fish, milk, egg, 
hazelnut, tomato and liver. ¶Antibodies were determined 6 months after the patients received 
13-valent pneumococcus conjugate vaccine. 
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Table 2 Overlapping and specific signs of DOCK8 deficiency and HIES 
 
DOCK8    DOCK8 & AD-HIES  AD-HIES 
     
Asthma   Atopic dermatitis  Characteristic face 
Allergies   Bacterial infections  Pneumatocele  
Viral infections  CMC    Retention of primary teeth 
Lymphopenia   Lymphoma   Pathologic fractures  
IgM↓; IgG↑; IgA↑↓  Eosinophilia   Hyper-extensible joints 
    High serum IgE level  Arched palate  
DOCK8, dedicator of cytokinesis; AD-HIES, autosomal dominant HIES; CMC, 
chronic mucocutaneous candidiasis; Ig, immunoglobulin. 
 
Figure legends 
Fig. 1  PCR amplification of DOCK8 gDNA and cDNA. (a) PCR amplification of 
DOCK8 exons 8 to 14 from the two patients and a control. The visible bands 
for exons 8 and 14 in patients result from the nonspecific binding of the 
primers to other genes. The lack of PCR products from the patients’s gDNA 
and the detection of such products with control gDNA suggested deletions of 
exons 8-14. (b) By contrast to the results obtained for the patients, DOCK8 
exons 8 to 14 could be amplified from the mother. (c) PCR amplification of the 
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full-length GADPH cDNA yielded a 244 bp band in both patients and the 
control (left). Amplification of the full-length DOCK8 suggested an absence of 
the cDNA from the patients’ samples and the presence of the 6249 bp DOCK8 
cDNA in the control (second from left). Amplification of DOCK8 exons 1 to 
15 suggested that this fragment was missing from the patients’ cells but present 
in the control and the mother (second from right). PCR amplification of exons 
3 to 26 of the DOCK8 cDNA yielded a 1590 bp product for patients, 
corresponding to an aberrantly spliced mRNA (right), and a 2800 bp product 
for the control and the mother. GADPH,  glyceraldehyde 3-phosphate 
dehydrogenase; bp, base pair; Mw, molecular weight; C, control; P1, Patient 
P1; P2, Patient P2; M, mother. 
Fig. 2  Automated sequencing profiles of exons 3-26 of DOCK8, with cDNA as the 
template. Del8-18 exon mutations of DOCK8 were found in both patients. P1, 
patient P1; P2, patient P2; aa, amino acid. 
Fig. 3 MLPA analysis of the DOCK8 gene. (Fig. 3a) Data for Patient P1 (black bars) 
and a healthy control (gray bars) are shown. Heterozygous deletions of exons 
1-7 and exons 15-18, as indicated by a lower fluorescence intensity, and a 
homozygous deletion ofrexons 8-14 as indicated by the lack of fluorescence 
intensity in P1. Downstream from exon 19, equivalent fluorescence intensity 
peaks were found, indicating the presence of wild-type sequences of these 
allele segments in P1 and the healthy control. An analysis of samples from t P2 
yielded similar results. (Fig. 3b and 3c) The heterozygous deletion of exons 8-
18 in the father (3b) and of exons 1-14 in the mother (3c) was demonstrated by 
MLPA. (Fig. 3d) Schematic representation of the heterozygosity of the exons 
1-14 deletion in the mother and the exons 8-18 deletion in the father, and 
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compound heterozygosity of the two new large deletions of DOCK8 found in 
patients P1 and P2.  
Fig. 4 Western blot analysis of DOCK8 protein in PBMC lysates. Experiments were 
performed with polyclonal antibodies against DOCK8 and PBMCs (50 μg of 
total lysate for control and 100 μg for the patients).  A 230 kDa protein band, 
corresponding to the DOCK8 protein, was detected in the control sample. By 
contrast, DOCK8 was undetectable in samples from the patients, despite the 
use of double the amount of protein lysate. kDa, kiloDalton; C, control; P1, 
patient 1; P2, patient 2; M, molecular weight standard. 
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